These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9157951)
1. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ Arterioscler Thromb Vasc Biol; 1997 May; 17(5):881-8. PubMed ID: 9157951 [TBL] [Abstract][Full Text] [Related]
2. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ J Lipid Res; 1997 Aug; 38(8):1535-43. PubMed ID: 9300775 [TBL] [Abstract][Full Text] [Related]
3. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998 [TBL] [Abstract][Full Text] [Related]
4. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. Millar JS; Lichtenstein AH; Cuchel M; Dolnikowski GG; Hachey DL; Cohn JS; Schaefer EJ J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994 [TBL] [Abstract][Full Text] [Related]
5. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821 [TBL] [Abstract][Full Text] [Related]
6. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
7. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415 [TBL] [Abstract][Full Text] [Related]
10. Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo. Parhofer KG; Barrett PH; Bier DM; Schonfeld G J Clin Invest; 1992 Jun; 89(6):1931-7. PubMed ID: 1602000 [TBL] [Abstract][Full Text] [Related]
11. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585 [TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2966-74. PubMed ID: 10591677 [TBL] [Abstract][Full Text] [Related]
13. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity. Pont F; Duvillard L; Florentin E; Gambert P; Vergès B Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756 [TBL] [Abstract][Full Text] [Related]
14. Turnover of 125I-VLDL and 131I-LDL apolipoprotein B in rabbits fed diets containing casein or soy protein. Khosla P; Samman S; Carroll KK; Huff MW Biochim Biophys Acta; 1989 Apr; 1002(2):157-63. PubMed ID: 2930765 [TBL] [Abstract][Full Text] [Related]
15. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia. Elias N; Patterson BW; Schonfeld G Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523 [TBL] [Abstract][Full Text] [Related]
17. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941 [TBL] [Abstract][Full Text] [Related]
18. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893 [TBL] [Abstract][Full Text] [Related]
19. Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia. Parhofer KG; Barrett PH; Demant T; Richter WO; Schwandt P J Lipid Res; 1996 Nov; 37(11):2383-93. PubMed ID: 8978490 [TBL] [Abstract][Full Text] [Related]
20. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. Parhofer KG; Hugh P; Barrett R; Bier DM; Schonfeld G J Lipid Res; 1991 Aug; 32(8):1311-23. PubMed ID: 1770313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]